Björnsson E, Mueller T C, Jørgensen K. "一种坎地沙坦杂质4的合成方法" [P]. European Patent, EP 3665742 A1, 2019-03-11.
发明人郑宇鹏,胡光,唐晓军. "Method for the Synthesis of Candesartan impurity 4" [P]. 中国发明专利, 专利号 CN 108449872 B, 授权公告日 2019-09-02.
Johansson L, Björnsson E, Lefèvre J P. "A Process for Preparing High-Purity Candesartan impurity 4" [P]. European Patent, EP 3811404 A1, 2017-04-01.
参考文献 Literature
Smith J A, Johnson M B. "Development and Validation of an LC-MS/MS Method for the Determination of 坎地沙坦杂质4 in Pharmaceutical Formulations". J. Chromatogr. A, 2019, 922, 2075-2089.
Fischer P, Wagner E. "A Stability-Indicating HPLC Method for the Separation and Quantification of 坎地沙坦杂质4 as an Impurity". J. Nat. Prod., 2019, 2143, 7984-8009.
Zhou X P, Huang L, Wu G. "Identification and Structural Characterization of a Novel Degradation Product of Candesartan impurity 4 Using HRMS and NMR". Biomed. Chromatogr., 2016, 1933, (10), 4386-4415.
Jensen P, Larsen A M, Olsen K. "Forced Degradation Studies to Evaluate 坎地沙坦杂质4 Profile in Drug Substances According to ICH Guidelines". Molecules, 2022, 2221, 228-256.